Intimation of Participation in Investor meet at BofA 2026 India Conference at Mumbai
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aurobindo Pharma has informed exchanges that company officials will participate in the BofA 2026 India Conference in Mumbai on June 2, 2026. The meeting is scheduled from 9:00 AM to 6:00 PM IST and will include in-person and group meetings. The company has explicitly stated that no Unpublished Price Sensitive Information (UPSI) will be discussed during the interactions. This is a routine regulatory disclosure under SEBI listing obligations for investor engagement activities.
This is a standard investor relations activity disclosure with no direct impact on the stock. The explicit mention that no UPSI will be shared is a standard compliance safeguard, providing transparency to investors about the nature of investor communications.